Back to Search
Start Over
Sarbanes - Oxley Act proving costly for US biotech
- Source :
- SCRIP World Pharmaceutical News. March 4, 2005 Issue 3034, p16, 1 p.
- Publication Year :
- 2005
-
Abstract
- The enforcement of the Sarbanes-Oxley Act has increased the workload and cost compliance for companies in the United States, as it demands increased transparency and accountability in companies. An analysis is done on the economic influence of the Act on the biotechnology industry of the country.
Details
- Language :
- English
- ISSN :
- 01437690
- Issue :
- 3034
- Database :
- Gale General OneFile
- Journal :
- SCRIP World Pharmaceutical News
- Publication Type :
- Periodical
- Accession number :
- edsgcl.130951942